Comparison · NSE · data 2026-11-02
Quest Laboratories Ltd. vs Sotac Pharmaceuticals Limited
In plain words
Size: Quest Laboratories Ltd. is about 1.1 times the market value of Sotac Pharmaceuticals Limited.
Valuation (P/E): Sotac Pharmaceuticals Limited 21.4 vs Quest Laboratories Ltd. 9.
Return on equity: Quest Laboratories Ltd. 16.7% vs Sotac Pharmaceuticals Limited 10.3%.
Profit growth over 3 years: Quest Laboratories Ltd. 43.4% a year vs Sotac Pharmaceuticals Limited 26.1% a year.
Debt to equity: Sotac Pharmaceuticals Limited 0.64 vs Quest Laboratories Ltd. 0.08.
Differences in the numbers, not a recommendation of either stock.
Side by side
| QUESTLAB | SOTAC | |
|---|---|---|
| Price | ₹82 | ₹111.65 |
| Market cap | ₹134 cr | ₹123 cr |
| P/E | 9 | 21.4 |
| P/B | 1.4 | 2.1 |
| ROE | 16.7% | 10.3% |
| ROCE | 19.3% | 17.4% |
| Debt / equity | 0.08 | 0.64 |
| Operating margin | 15.6% | 8.6% |
| Dividend yield | 0.00% | 0.18% |
| Sales growth, 3 years (yearly) | 22.0% | 9.3% |
| Profit growth, 3 years (yearly) | 43.4% | 26.1% |
| 1-year return | -6.8% | -6.1% |
| Revenue, last 12 months | ₹112 cr | ₹97 cr |
| Net profit, last 12 months | ₹15 cr | ₹6 cr |
| Latest quarter | — | — |
| Quarter net profit | — | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | — |
| Health check | Strong (7.3/10) | Strong (7.2/10) |
Common questions
Which has a higher P/E, Quest Laboratories Ltd. or Sotac Pharmaceuticals Limited?
Sotac Pharmaceuticals Limited trades at the higher P/E (21.4 against 9). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Quest Laboratories Ltd. (16.7% against 10.3%).
Which carries more debt?
Sotac Pharmaceuticals Limited has the higher debt-to-equity ratio (0.64 against 0.08).